SE460095B - Injicerbar komposition innefattande 1-(2-hydroxietyl)-2-metyl-5-nitroimidazol samt foerpackning foer framstaellning daerav - Google Patents

Injicerbar komposition innefattande 1-(2-hydroxietyl)-2-metyl-5-nitroimidazol samt foerpackning foer framstaellning daerav

Info

Publication number
SE460095B
SE460095B SE8404130A SE8404130A SE460095B SE 460095 B SE460095 B SE 460095B SE 8404130 A SE8404130 A SE 8404130A SE 8404130 A SE8404130 A SE 8404130A SE 460095 B SE460095 B SE 460095B
Authority
SE
Sweden
Prior art keywords
particles
metronidazole
weight
suspension
dimension
Prior art date
Application number
SE8404130A
Other languages
English (en)
Swedish (sv)
Other versions
SE8404130L (sv
SE8404130D0 (sv
Inventor
J H Bell
R P Haslam
A Lewis
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of SE8404130D0 publication Critical patent/SE8404130D0/xx
Publication of SE8404130L publication Critical patent/SE8404130L/
Publication of SE460095B publication Critical patent/SE460095B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SE8404130A 1983-08-19 1984-08-17 Injicerbar komposition innefattande 1-(2-hydroxietyl)-2-metyl-5-nitroimidazol samt foerpackning foer framstaellning daerav SE460095B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838322364A GB8322364D0 (en) 1983-08-19 1983-08-19 Compositions of matter

Publications (3)

Publication Number Publication Date
SE8404130D0 SE8404130D0 (sv) 1984-08-17
SE8404130L SE8404130L (sv) 1985-02-20
SE460095B true SE460095B (sv) 1989-09-11

Family

ID=10547557

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8404130A SE460095B (sv) 1983-08-19 1984-08-17 Injicerbar komposition innefattande 1-(2-hydroxietyl)-2-metyl-5-nitroimidazol samt foerpackning foer framstaellning daerav

Country Status (17)

Country Link
JP (1) JPS6067468A (fr)
AU (1) AU577055B2 (fr)
BE (1) BE900381A (fr)
CA (1) CA1214727A (fr)
CH (1) CH662812A5 (fr)
DE (1) DE3430354A1 (fr)
DK (1) DK165817C (fr)
FR (1) FR2560043B1 (fr)
GB (2) GB8322364D0 (fr)
HU (1) HU192990B (fr)
IL (1) IL72714A (fr)
IT (1) IT1213208B (fr)
LU (1) LU85511A1 (fr)
NL (1) NL8402510A (fr)
NZ (1) NZ209270A (fr)
SE (1) SE460095B (fr)
ZA (1) ZA846431B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU205861B (en) * 1986-12-19 1992-07-28 Sandoz Ag Process for producing hydrosole of pharmaceutically effective material
US7849856B2 (en) 2001-06-25 2010-12-14 3M Innovative Properties Company Respirator valve

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB213928A (en) * 1923-04-06 1925-07-02 Deutsche Werke Ag Improvements in or relating to compensated induction motors for single or polyphase alternating current
US3457348A (en) * 1966-06-27 1969-07-22 American Cyanamid Co Stable syringeable suspensions of parenteral drugs in complex floc form
GB1430411A (en) * 1973-04-05 1976-03-31 May & Baker Ltd Method and compositions for combating swine dysentery
US4029782A (en) * 1975-04-28 1977-06-14 Eli Lilly And Company Cefazolin suspension for parenteral administration
GB2000025A (en) * 1977-05-14 1979-01-04 Pfizer Ltd Nitroimidazole formulations
DE2932691A1 (de) * 1979-08-11 1981-04-09 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoeherer freisetzung der wirkstoffe

Also Published As

Publication number Publication date
LU85511A1 (fr) 1985-04-24
DE3430354A1 (de) 1985-03-07
GB8322364D0 (en) 1983-09-21
GB2145088B (en) 1986-10-08
CA1214727A (fr) 1986-12-02
DK397084D0 (da) 1984-08-17
ZA846431B (en) 1985-03-27
IL72714A (en) 1988-09-30
HUT35650A (en) 1985-07-29
IT1213208B (it) 1989-12-14
DK165817C (da) 1993-06-21
DK165817B (da) 1993-01-25
HU192990B (en) 1987-08-28
IT8422323A0 (it) 1984-08-13
BE900381A (fr) 1985-02-18
NL8402510A (nl) 1985-03-18
JPS6067468A (ja) 1985-04-17
DK397084A (da) 1985-02-20
AU577055B2 (en) 1988-09-15
GB2145088A (en) 1985-03-20
NZ209270A (en) 1988-02-29
SE8404130L (sv) 1985-02-20
AU3202284A (en) 1985-02-21
CH662812A5 (fr) 1987-10-30
FR2560043B1 (fr) 1988-08-05
FR2560043A1 (fr) 1985-08-30
GB8420959D0 (en) 1984-09-19
SE8404130D0 (sv) 1984-08-17

Similar Documents

Publication Publication Date Title
RU2142229C1 (ru) Водная многофазная, устойчивая готовая препаративная форма для защиты растений и способ ее получения
AU2010325632B2 (en) Process for preparing pharmaceutical ophthalmic compositions
JP5810098B2 (ja) 水性眼科組成物
DK2364137T3 (en) Pharmaceutical suspension
JPH06501258A (ja) 非水性のパーフルオロ化担体中に懸濁したドラッグデリバリー賦形剤
US4087538A (en) Ophthalmic suspensions
AU646440B2 (en) Liquid pesticide concentrates
DE60215129T2 (de) Esmolol-enthaltende zubereitungen
SE460095B (sv) Injicerbar komposition innefattande 1-(2-hydroxietyl)-2-metyl-5-nitroimidazol samt foerpackning foer framstaellning daerav
US10463674B2 (en) Process for manufacturing sterile ophthalmic pharmaceutical suspensions
CZ104197A3 (en) Pharmaceutical preparation
CN105997873A (zh) 一种水包油型特拉唑嗪纳米乳抗高血压药物
CN107595772A (zh) 一种他克莫司纳米混悬滴眼液的制备方法
Ali et al. Pharmaceutical development of suspension dosage form
AU2013290826B2 (en) Injectable antibiotic formulations and their methods of use
US9820991B2 (en) Pharmaceutical composition comprising brinzolamide
US4093733A (en) Parenteral suspensions
KR850000991B1 (ko) 살충용 수성 현탁액
JPH11319028A (ja) 点眼剤

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8404130-0

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8404130-0

Format of ref document f/p: F